BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Valletti A, Marzano F, Pesole G, Sbisà E, Tullo A. Targeting Chemoresistant Tumors: Could TRIM Proteins-p53 Axis Be a Possible Answer? Int J Mol Sci 2019;20:E1776. [PMID: 30974870 DOI: 10.3390/ijms20071776] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Bhaduri U, Merla G. Rise of TRIM8: A Molecule of Duality. Mol Ther Nucleic Acids 2020;22:434-44. [PMID: 33230447 DOI: 10.1016/j.omtn.2020.08.034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
2 Marzano F, Caratozzolo MF, Pesole G, Sbisà E, Tullo A. TRIM Proteins in Colorectal Cancer: TRIM8 as a Promising Therapeutic Target in Chemo Resistance. Biomedicines 2021;9:241. [PMID: 33673719 DOI: 10.3390/biomedicines9030241] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Xia C, Liu C, He Z, Cai Y, Chen J. Metformin inhibits cervical cancer cell proliferation by modulating PI3K/Akt-induced major histocompatibility complex class I-related chain A gene expression. J Exp Clin Cancer Res 2020;39:127. [PMID: 32631421 DOI: 10.1186/s13046-020-01627-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
4 Mandell MA, Saha B, Thompson TA. The Tripartite Nexus: Autophagy, Cancer, and Tripartite Motif-Containing Protein Family Members. Front Pharmacol 2020;11:308. [PMID: 32226386 DOI: 10.3389/fphar.2020.00308] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
5 Jin Y, Zhao X, Zhang Q, Zhang Y, Fu X, Hu X, Wan Y. Cancer-associated mutation abolishes the impact of TRIM21 on the invasion of breast cancer cells. International Journal of Biological Macromolecules 2020;142:782-9. [DOI: 10.1016/j.ijbiomac.2019.10.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Cai Y, Zhang J, Xin T, Xu S, Liu X, Gao Y, Huang H. Eleutheroside E functions as anti-cervical cancer drug by inhibiting the phosphatidylinositol 3-kinase pathway and reprogramming the metabolic responses. J Pharm Pharmacol 2022:rgac047. [PMID: 35789274 DOI: 10.1093/jpp/rgac047] [Reference Citation Analysis]
7 Xing L, Tang X, Wu K, Huang X, Yi Y, Huan J. TRIM27 Functions as a Novel Oncogene in Non-Triple-Negative Breast Cancer by Blocking Cellular Senescence through p21 Ubiquitination. Mol Ther Nucleic Acids 2020;22:910-23. [PMID: 33251042 DOI: 10.1016/j.omtn.2020.10.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
8 Zhao G, Liu C, Wen X, Luan G, Xie L, Guo X. The translational values of TRIM family in pan-cancers: From functions and mechanisms to clinics. Pharmacol Ther 2021;227:107881. [PMID: 33930453 DOI: 10.1016/j.pharmthera.2021.107881] [Reference Citation Analysis]
9 Han Y, Tan Y, Zhao Y, Zhang Y, He X, Yu L, Jiang H, Lu H, Tian H. TRIM23 overexpression is a poor prognostic factor and contributes to carcinogenesis in colorectal cancer. J Cell Mol Med 2020;24:5491-500. [PMID: 32227572 DOI: 10.1111/jcmm.15203] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
10 Riganti C, Contino M. New Strategies to Overcome Resistance to Chemotherapy and Immune System in Cancer. Int J Mol Sci 2019;20:E4783. [PMID: 31561494 DOI: 10.3390/ijms20194783] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
11 Eberhardt W, Haeussler K, Nasrullah U, Pfeilschifter J. Multifaceted Roles of TRIM Proteins in Colorectal Carcinoma. Int J Mol Sci 2020;21:E7532. [PMID: 33066016 DOI: 10.3390/ijms21207532] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Caratozzolo MF, Marzano F, Abbrescia DI, Mastropasqua F, Petruzzella V, Calabrò V, Pesole G, Sbisà E, Guerrini L, Tullo A. TRIM8 Blunts the Pro-proliferative Action of ΔNp63α in a p53 Wild-Type Background. Front Oncol 2019;9:1154. [PMID: 31781486 DOI: 10.3389/fonc.2019.01154] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
13 Liu J, Zhang C, Wang X, Hu W, Feng Z. Tumor suppressor p53 cross-talks with TRIM family proteins. Genes Dis 2021;8:463-74. [PMID: 34179310 DOI: 10.1016/j.gendis.2020.07.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Marzano F, Guerrini L, Pesole G, Sbisà E, Tullo A. Emerging Roles of TRIM8 in Health and Disease. Cells 2021;10:561. [PMID: 33807506 DOI: 10.3390/cells10030561] [Reference Citation Analysis]
15 Zhou Z, Shu Y, Bao H, Han S, Liu Z, Zhao N, Yuan W, Jian C, Shu X. Stress-induced epinephrine promotes epithelial-to-mesenchymal transition and stemness of CRC through the CEBPB/TRIM2/P53 axis. J Transl Med 2022;20. [DOI: 10.1186/s12967-022-03467-8] [Reference Citation Analysis]
16 Liu R, Li H, Xu Y, Li X, Guo X, Shi J, Cui Y, Wang Z, Liu J. Blockade of TRIM59 enhances esophageal cancer cell chemosensitivity to cisplatin by upregulating p53. Oncol Lett 2021;21:6. [PMID: 33240412 DOI: 10.3892/ol.2020.12267] [Reference Citation Analysis]